Day 2 - 17th October - EST/EDT (Eastern Daylight, GMT-4)
Day 2 - 17th October - EST/EDT (Eastern Daylight, GMT-4)
a. How can choosing the correct IRT system help optimize supply, reduce costs, and eliminate unnecessary wate in supply chains?
b. Automated processes and how this simplifies logistics.
c. Integrating or transferring data between IRT and forecasting systems to compare planned versus actual.
- Kamal Amin - Head Of Supply Chain Management, Galderma
- Irena Seredina - Executive Director, S-CLINICA
- Aiste Stulpiniene - Clinical Supply IRT Lead, F. Hoffmann-La Roche Ltd
As clinical trials are getting more and more complicated, and the race to deliver continues to get faster and more demanding, then Interactive Response Technology (IRT) becomes even more on the critical path. Leveraging configurable IRT as a start and end point in this race can help speed up the trial, improving experience for sponsors, sites and patients.
- Mike Hutton - Head of Strategic Partnership Alliances, Almac
- John Ranz - Chief Technology Officer, Atreo
e. What do actual end users want (including sponsors and sites)
f. What standardisation is required around systems and what does this look like?
g. Tech integration for different end users – needs and requirements.
h. How can we make systems use friendly to ensure that IRT and supply chain managers can work hand in hand to get the right product to the right patient?
i. IRT vs. RTSM
a. How you differentiate between e-tech like eCOA or e-consent?
b. Are these technologies better integrated or as stand alone?
c. When using these how do you prevent IRT just becoming a clinical database?
- Bryan Clayton - Founder, BC Consulting
a. Integrating and building reports across protocols
b. How can data from IRT systems be analysed and influence shipping etc to cut costs.
c. Working to create more efficient systems vs. having to make the same change across multiple systems and studies.